Skip to main content
Clinical Trials/NCT00258791
NCT00258791WithdrawnNot Applicable

Effects of Pretreatment With Ibuprofen in Post- ECT Headache

Norwegian University of Science and Technology0 sitesStarted: January 1, 2012Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn

Study Overview

Brief Summary

The purpose of the study is to determine whether ibuprofen reduces post-ECT headache or reduces its severity.

Detailed Description

The aim of the study is to compare the severity of headache between patients who are receiving ibuprofen prior to ECT treatment with patients receiving placebo prior to ECT treatment.

Patients will be randomly assigned to receive either 600 mg ibuprofen 90 min prior to treatment or placebo orally, blinded to patient, physician and treatment team.

Patients will be asked about their headache with a visual analogue scale (VAS) 2 hours prior to and within 2 hours after treatment, 2-month, 6- month and 1 year follow-up [5].

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients receiving ECT

Exclusion Criteria

  • Pregnancy, contraindications to ibuprofen

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials